Nancy Ryan Gray insider trades

Open-market stock purchases and sales by Nancy Ryan Gray, Director at Ligand Pharmaceuticals Inc, from SEC Form 4 filings since Aug 18, 2017.

Recent trades

DateStockTradeValue
Jun 5, 2026LGND Ligand Pharmaceuticals IncBought (not open market)—
Jun 5, 2026LGND Ligand Pharmaceuticals IncBought (not open market)—
Nov 7, 2025LGND Ligand Pharmaceuticals IncSold$731K
Nov 7, 2025LGND Ligand Pharmaceuticals IncSold$619K
Nov 7, 2025LGND Ligand Pharmaceuticals IncBought (not open market)—
Nov 7, 2025LGND Ligand Pharmaceuticals IncBought (not open market)—

Companies traded

  • LGND Ligand Pharmaceuticals Inc: 3 sales, last Jun 5, 2026

Get free alerts when Nancy Ryan Gray files a new trade →